NCT07407933 2026-02-12
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2 Not yet recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
AstraZeneca
Qilu Pharmaceutical Co., Ltd.
Assiut University
Aga Khan University